Progyny PGNY Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $131.61M+17.3% | $112.24M-16.2% | $133.98M+1.1% | $132.51M+21.3% | $109.24M-32.7% | ||
| $93.5M-52.7% | $197.86M-6.3% | $211.23M+22.4% | $172.59M+17.5% | $146.88M+124% | ||
| $1.01B-3.5% | $1.04B-1.4% | $1.06B-2.6% | $1.09B-2.0% | $1.11B+0.2% | ||
| $501.55M-9.1% | $551.78M-11.3% | $622.01M+4.6% | $594.4M+4.7% | $567.69M+20.1% | ||
| $35.71M+19.3% | $29.93M+21.0% | $24.74M+24.1% | $19.94M+26.7% | $15.74M+27.1% | ||
| $19.88M-0.5% | $19.98M+0.1% | $19.96M0.0% | $19.96M+1.6% | $19.65M+26.5% | ||
| $5.97M-3.9% | $6.22M-3.3% | $6.43M-3.3% | $6.64M-1.6% | $6.75M— | ||
| $698.34M-5.9% | $742.44M-6.6% | $795.23M+4.5% | $760.95M+4.2% | $730.29M+20.3% | ||
| $545.5M+2.3% | $533.39M+5.7% | $504.42M-1.4% | $511.79M-2.1% | $523.02M+3.1% | ||
| $235.74M+16.5% | $202.39M-3.8% | $210.49M-4.5% | $220.42M-7.0% | $237.13M+40.6% | ||
| $258.99M+14.4% | $226.39M-3.8% | $235.22M-4.4% | $245.93M-6.5% | $263.13M+42.2% | ||
| $9K0.0% | $9K0.0% | $9K0.0% | $9K0.0% | $9K0.0% | ||
| $227.06M+11.9% | $202.83M+6.6% | $190.34M+7.9% | $176.48M+10.7% | $159.37M+10.4% | ||
| $439.34M-14.9% | $516.04M-7.8% | $560M+8.7% | $515.02M+10.2% | $467.16M+10.7% | ||
| $698.34M-5.9% | $742.44M-6.6% | $795.23M+4.5% | $760.95M+4.2% | $730.29M+20.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Progyny cover its short-term obligations?
- Its current ratio is 2.13 — current assets exceed current liabilities.
- Where does Progyny's balance sheet data come from?
- Every line is extracted from Progyny's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.